Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Alprostadil 500 mcg/mL Injectable Recalled by Westlab Pharmacy, Inc. dba Westlab Pharmacy Due to Incorrect Product Formulation
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Westlab Pharmacy, Inc. dba Westlab Pharmacy directly.
Affected Products
Alprostadil 500 mcg/mL Injectable, Vials, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-7335-00
Quantity: 80 syringes
Why Was This Recalled?
Incorrect Product Formulation
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Westlab Pharmacy, Inc. dba Westlab Pharmacy
Westlab Pharmacy, Inc. dba Westlab Pharmacy has 3 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report